[go: nahoru, domu]

Jump to content

5-HT2C receptor: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

28 August 2024

12 August 2024

18 July 2024

28 June 2024

22 February 2024

14 December 2023

19 November 2023

28 August 2023

14 August 2023

12 August 2023

1 August 2023

  • curprev 15:3415:34, 1 August 2023Oro Temp talk contribsm 51,821 bytes +36 →‎Function: There is no human evidence that I'm aware of to support the idea that agomelatine's clinical efficacy is in any way mediated by 5ht2c antagonism. Agomelatine fails to increase SWS acutely, a well-known property of clinically significant 5ht2c receptor antagonists in human beings. undo Tag: Visual edit

18 February 2023

6 February 2023

29 January 2023

3 September 2022

20 August 2022

8 July 2022

13 May 2022

3 May 2022

8 February 2022

6 February 2022

7 December 2021

27 November 2021

20 October 2021

20 August 2021

18 August 2021

23 July 2021

6 July 2021

20 June 2021

16 May 2021

28 April 2021

26 April 2021

25 March 2021

2 January 2021

3 December 2020

30 November 2020

8 September 2020

7 September 2020

27 August 2020

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)